Mathematical modelling company Physiomics, which specialises in the development of oncology drugs and personalised medicine, confirmed a renewed contract with Numab Therapeutics on Tuesday.
Shares of Physiomics Plc (LON:PYC – Get Rating) reached a new 52-week low on Tuesday . The company traded as low as GBX 1 ($0.01) and last traded at GBX 1.03 ($0.01), with a volume of 7187274 shares changing hands. The stock had previously closed at GBX 2.05 ($0.03). Physiomics Stock Down 49.8 % The […]
Physiomics Plc (LON:PYC – Get Rating) was up 2.5% during mid-day trading on Monday . The company traded as high as GBX 2.05 ($0.03) and last traded at GBX 2.05 ($0.03). Approximately 171,364 shares traded hands during trading, a decline of 73% from the average daily volume of 640,406 shares. The stock had previously closed […]